Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02367482 · ClinicalTrials.gov registry record
Tryptophan Metabolism in Human Brain Tumors-Novocure
A clinical trial, sponsored by Wayne State University.
- Completed
- Registry status
- 20
- Enrollment target
NCT02367482 is a clinical trial that has completed, run by Wayne State University. The registered enrollment target is 20 participants.
The verdict
NCT02367482 has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
In this research study, we will track the build-up of tryptophan, a radioactive tracer, in the brain using positron emission tomography (PET) scanning. Tryptophan, in its natural state, is an amino acid (one of the building blocks of proteins) that is normally present in the brain, and is used by the brain cells to create various other compounds. This process is altered in the presence of a brain tumor. By using a form of tryptophan marked with a small amount of radiation, we will be able to track this process during the course of the PET scan. This research will help determine if AMT PET is a useful method to recognize and differentiate between various types of brain tumors. In addition, to study the mechanisms of altered tryptophan uptake in the tumor and brain, we will also measure tryptophan levels and related molecules in your blood (obtained as a part of the PET procedure) and tumor tissue (in case you will have surgery to remove the tumor). This will help us to find new approaches to treat brain tumors in the future by altering abnormal tryptophan metabolism.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-07 |
| Est. Completion | 2023-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02367482
The ClinicalTrials.gov registry entry for NCT02367482 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02367482 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02367482 about?
NCT02367482 is a clinical study titled "Tryptophan Metabolism in Human Brain Tumors-Novocure". In this research study, we will track the build-up of tryptophan, a radioactive tracer, in the brain using positron emission tomography (PET) scanning. Tryptophan, in its natural state, is an amino acid (one of the building blocks of proteins) that is normally present in the brain, and is used by th...
What is the current status of trial NCT02367482?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2014-07. Estimated completion is 2023-12-31.
Who is sponsoring clinical trial NCT02367482?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.